耳穴压贴联合中药足浴对原发性高血压并发焦虑患者负性情绪、血压及心率的影响

目的探讨耳穴压贴联合中药足浴对原发性高血压并发焦虑患者负性情绪、血压及心率的影响。方法选取2013年10月~2015年10月我科收治的原发性高血压并发焦虑患者112例,随机分为对照组和观察组,各56例。对照组给予常规护理。观察组给予耳穴压贴联合中药足浴护理。比较两组护理前后HAMA评分、血压、心率的差异。结果观察组护理后精神性焦虑评分、躯体性焦虑评分和HAMA总评分均低于对照组(P0.05);观察组护理后收缩压、舒张压、心率均低于对照组(P0.05)。结论耳穴压贴联合中药足浴应用于原发性高血压并发焦虑患者,可有效缓解焦虑情绪,降低血压和心率。     

中药足浴联合耳穴压豆对失眠患者的疗效观察

目的观察耳穴压豆联合中药足浴对治疗失眠的疗效。方法选择2015年4月—2016年3月收治于上海中医药大学附属上海市中医医院失眠科的患者100例,按随机数字表分为两组,观察组48例采用耳穴压豆联合中药足浴的方法,对照组52例采用单纯中药足浴的方法。干预30 d后比较两组患者匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI)评分及总体疗效情况。结果中药足浴联合耳穴压豆较单纯中药足浴治疗失眠的疗效更佳(P0.05)。观察组患者睡眠质量、入睡时间、睡眠时间等得分均优于对照组,差异有统计学意义(P0.05);观察组失眠治疗的总有效率为75.00%,对照组为53.85%,差异有统计学意义(P0.05)。结论中药足浴联合耳穴压豆对缓解失眠有较为显著的疗效。     

中药足浴联合耳穴压豆对失眠患者的观察与护理

【】目的 观察耳穴压豆联合中药足浴对治疗失眠的效果。方法 将100例患者按随机数字表随机分为两组,观察组48例采用耳穴压豆联合中药足浴的方法,对照组52例单纯采用中药足浴的方法。干预20d后比较两组匹兹堡睡眠质量指数(PSQI)量表评分和总体疗效进行评价。结果 两组 PSQI总分较干预前均有所降低(P＜0.05),且观察组比对照组降低更为明显(P＜0.01,P＜0.05);两组睡眠质量、入睡时间、睡眠时间及睡眠效率得分差异有统计学意义(P＜0.05),且在睡眠质量项目方面观察组比对照组改善更为明显(P＜0.01)。观察组总有效率为75%,对照组的总有效率为54%,两组疗效比较差异有统计学意义(P＜0.05)。结论 中药足浴联合耳穴压豆治疗失眠的效果显著,值得临床推广使用。     

耳穴贴压配合穴位按摩应用于原发性高血压患者的效果观察

目的观察耳穴贴压配合穴位按摩应用于原发性高血压患者的效果。方法将100例原发性高血压患者随机分为观察组和对照组,每组各50例。对照组常规应用降压药治疗,观察组在此基础上加用耳穴贴压配合穴位按摩治疗。比较两组患者治疗前后血压的变化情况。结果两组治疗后收缩压及舒张压均显著低于治疗前,降压总有效率观察组为96%,对照组为90%,两组患者的血压控制有效率差异无统计学意义(P0.05);观察组患者的总有效率显著高于对照组,两组比较差异有统计学意义(P0.05)。结论耳穴贴压配合穴位按摩可作为高血压患者的一种辅助降压手段,能有效地降低血压,尤其对改善头痛、眩晕、急躁易怒等症状效果良好。     

择时应用中医三联疗法治疗非杓型原发性高血压病患者的临床疗效研究

目的：探讨子午流注理论择时联合应用中医三联疗法（耳穴贴压、中药足浴、穴位贴敷）对非杓型高血压病患者血压变化的干预效果。方法：将84例非杓型原发性高血压病患者随机分为观察组和对照组,每组各42例。对照组采用高血压药物治疗,并根据不同证候分型进行针灸治疗及相关常规护理措施。观察组给予常规护理外,开展耳穴贴压（7:30~7:45）、中药足浴（15:30~15:45）以及穴位贴敷（20:00~20:30）。干预2周后观察两组治疗前后动态血压变化和中医三联疗法的效果。结果：治疗后观察组血压均低于对照组,疗效优于对照组,差异具有统计学意义（P<0.05）。结论：子午流注理论择时联合应用中医三联疗法可有效平稳降低非杓型原发性高血压病患者的血压峰值和夜间血压,治疗效果良好。     

针刺结合中药足浴辅助治疗高血压病的疗效观察

目的观察针刺结合中药足浴辅助治疗高血压病的临床疗效。方法将80例原发性高血压患者随机分为观察组和对照组,每组各40例,对照组口服用硝苯地平缓释片治疗,观察组在此基础上予针刺联合中药足浴治疗,比较两组患者降压疗效、症状疗效及复发率。结果降压总有效率观察组为97．5％,对照组为90％,差异无统计学意义意义（x2=1．81,P〉0．05）;两组患者症状疗效观察组高于对照组,差异有统计学意义意义（x2=2．904,P〈0．05）;复发率对照组高于观察组,差异有统计学意义意义（x2=10．78,P〈0．05）。结论针刺联合中药足浴能有效地降低血压,对改善头痛、眩晕、心悸等症状效果良好,且有稳定血压效应。     

耳穴贴压配合降压药物治疗高血压1级患者临床疗效观察

目的:观察原发性高血压1级患者采用耳穴贴压治疗后的临床疗效。方法:选取2015年10月至2017年10月确诊为原发性高血压1级的120例患者,随机分为降压药物组、耳穴贴压组、降压药物配合耳穴贴压组三组,每组各40例。分别给予降压药物治疗、中医辨证耳穴贴压治疗和降压药物配合中医辨证耳穴贴压治疗,治疗时间为4周。结果:经治疗,耳穴贴压配合降压药物组与其他两组进行对比,总有效率92.5%,主要症状改善95.0%,降压效果明显。差异有统计学意义(P<0.05)。结论:降压药物配合耳穴贴压组降压效果明显。     

耳穴压豆联合中药穴位贴敷治疗慢性胃炎胃痛的疗效观察

目的:观察耳穴压豆联合中药穴位贴敷治疗慢性胃炎胃痛的疗效。方法:选取2017年1月~2018年12月收治的80例慢性胃炎胃痛患者,按照随机分组原则分成对照组和观察组,各40例。对照组接受常规治疗,观察组在对照组基础上接受耳穴压豆及中药穴位贴敷治疗,比较两组临床疗效、疼痛评分及症状评分。结果:观察组治疗总有效率显著高于对照组,差异有统计学意义(P<0.05);治疗后观察组患者疼痛评分及症状评分显著低于对照组,差异有统计学意义(P<0.05)。结论:在常规治疗基础上,慢性胃炎胃痛患者接受耳穴压豆联合中药穴位贴敷治疗,更有助于减轻患者胃痛程度,有效缓解临床症状,提高临床疗效。     

中医耳穴治疗对原发性高血压并发焦虑患者的影响

目的 观察中医耳穴疗法对住院原发性高血压并发焦虑患者的影响.方法将70例原发性高血压并发焦虑患者按照Pocock和Simon最小化法随机分组,观察组37例,行常规护理及耳穴贴压治疗;对照组33例,只进行常规护理.入组当天和出院时进行汉密尔顿焦虑量表(HAMA)测评并记录血压变化.结果观察组降压有效率显著高于对照组,差异有统计学意义(P＜0.01),观察组血压、HAMA总分、精神性和躯体性焦虑因子分在干预后较对照组改善明显,差异有统计学意义(P＜0.01);躯体性焦虑因子中改善明显的为失眠和焦虑心境(P＜0.05);精神性焦虑因子中改善明显的为心血管、呼吸和感觉系统症状(P＜0.05).结论 中医耳穴疗法有辅助降压、抗焦虑的作用.     

耳穴压豆联合胸痹足浴方护理对冠心病心绞痛的效果观察

目的:探讨耳穴压豆联合胸痹足浴方护理对冠心病心绞痛的效果。方法:选取2019年3月至2019年8月本院收治的80例冠心病心绞痛患者,随机分为两组。对照组使用常规护理,观察组使用耳穴压豆联合胸痹足浴方。对比两组的临床效果。结果:观察组的有效率明显高于对照组(P<0.05);护理后,两组的健康指数、情感指数、生活满意度和感情指数明显升高(P<0.05),观察组的各指标值明显高于对照组(P<0.05)。结论:耳穴压豆联合胸痹足浴方护理对冠心病心绞痛患者具有比较满意的效果。     

珍菊降压片联合缬沙坦治疗原发性高血压(肝阳上亢证)患者的疗效观察

目的:观察珍菊降压片联合血管紧张素Ⅱ受体拮抗剂(angiotensinⅡreceptor blocker,ARB)缬沙坦治疗高血压(肝阳上亢证)的疗效。方法:将原发性高血压(中医辨证为肝阳上亢证)患者60例随机分为治疗组(珍菊降压片+缬沙坦)32例与对照组(双氢克脲噻+缬沙坦)28例,经8周治疗后,观察两组治疗前后动态血压、血压变异性及中医症状评分的变化。结果:治疗后与对照组比较,治疗组平均收缩压(systolic blood pressure,SBP)、白昼SBP(daytime mean SBP,d-SBP)、夜间SBP(nighttime mean SBP,n-SBP)均明显降低(P0.05),而两组平均舒张压(diastolic blood pressure,DBP)、白昼DBP(daytime mean DBP,d-DBP)、夜间DBP(nighttime mean DBP,n-DBP)差异则无统计学意义(P0.05);治疗组白昼SBP变异性(d-SBPV)、夜间SBP变异性(n-SBPV)均明显降低(P0.01),而两组白昼DBP变异性(d-DBPV)、夜间DBP变异性(n-DBPV)差异则无统计学意义(P0.05);治疗组中医症状(眩晕、头痛、易怒)评分均明显降低(P0.05),而两组肢体麻木症状积分差异则无统计学意义(P0.05)。结论:珍菊降压片联合缬沙坦治疗原发性高血压(肝阳上亢证)患者不仅可有效降低血压,改善血压变异性,还能改善患者的临床症状。     

高原地区以卡托普利缓释片为基础的联合降压治疗对高危高血压住院患者血压控制的影响

目的 探讨高海拔地区高危高血压住院患者以卡托普利缓释片为基础的联合降压治疗效果.方法 331例住院高血压患者依据血压值、危险因素和合并靶器官损害分为高危组(229例)和低危组(102例),高危组给予以卡托普利缓释片为基础的联合降血压治疗,低危组给予单一降压治疗,比较2组出院血压水平以及住院期间的降压幅度和出院血压达标率.结果 高危组患者收缩压、舒张压降压幅度均显著大于低危组[收缩压降幅分别为(36.83 ±22.23)、(28.74±18.71)mm Hg,舒张压降幅分别为(22.04±13.57)、(17.98±13.63)mm Hg,t值分别为-3.207、-2.509,P均<0.05),出院时平均收缩压[(125.62±14.74)、(122.28±13.13)mm Hg,t=-1.962]、舒张压[(80.67±9.82)、(78.40±9.97)mm Hg,t=-1.910]均达标且2组间比较差异无统计学意义(P均>0.05).住院期间血压治疗控制率高危组为72.06%(165/229),低危组为71.57%(73/102),2组间比较差异无统计学意义(x2=0.928,P>O.05).结论 在高海拔地区以卡托普利缓释片为基础的联合降压治疗是适合高危高血压患者降压治疗方案,能取得较满意的血压治疗控制率.

Abstract：

Objective To investigate the blood pressure control effect of captopril sustained-releasetablets based combination, antihypertensive therapy on hospitalized high-risk patients with hypertension in high altitude region. Methods According to the blood pressure,risk factors and combined target organ damage,331 hospitalized patients with essential hypertension were divided into 2 groups and accepted different treatment:low-risk group had monotherapy (n=102) , and night-risk group had captopril sustained-release-tablets based combination antihypertensive therapy (n =229). The discharge blood pressure,extent of SBP/DBP decrease and the compliance rate of discharge blood pressure of two groups were compared. Results The extent of SBP/DBP decrease in hight-risk group was significantly greater than low-risk group (SBP [36. 83 ± 22. 23] mm Hg vs.[28. 74 ±18.71] mm Hg,t=-3. 207,P <0. 05;DBP[22. 04±13. 57]mm Hg vs. [17. 98 ± 13.63] mm Hg,t =-2. 509, P < 0.05). The average discharge blood pressure in both groups reach the standard criterion, but no significant difference was observed between the two groups (SBP [125. 62 ± 14. 74] mm Hg vs. [122. 28 ±13.13]mmHg,t=-1. 962,P>0. 05;DBP[80. 67 ±9. 82]mm Hg vs. [78. 40 ±9. 97]mm Hg,t =-1.910,P > 0. 05). Furthermore we found no significant difference in the control rate of blood pressure between high-risk and low-risk group (72. 06% vs. 71. 57% , x2 = 0.928, P > 0. 05). Conclusion The captopril sustainedrelease-tablets based combination antihypertensive therapy is a reliable treatment in high-risk patients with hypertension from high altitude region,which shows satisfying blood pressure control rate.     

原发性高血压患者早期降压治疗后血压变异性、血压昼夜节律及靶器官损伤的变化

目的评估初诊未经治疗的原发性高血压患者经过早期正规降压治疗后能否改善血压变异性、血压昼夜节律以及靶器官损伤。方法选取2017年8月至2018年8月于安徽省立医院心血管内科门诊或体检中心初步确诊未经降压治疗的原发性高血压患者100例。根据每个患者的特点选用合适的药物进行降压治疗,按3个月内血压能否降至<130/80 mmHg将研究对象分为达标组(87例)和未达标组(13例)。分析入组前以及1年后两组患者的一般生化检查、血压变异性、血压昼夜节律、肱踝脉搏波传导速度(BaPWV)、左心室质量指数(LVMI)及尿微量白蛋白。结果治疗后,两组的SBP、DBP均可控制达标(P<0.05),但组间比较,差异无统计学意义(P>0.05);治疗后,两组的24 h SSD、dSSD、nSSD均改善,且达标组优于未达标组,差异具有统计学意义(P<0.05);治疗后,两组的24 h DSD、dDSD、n DSD比较,差异无统计学意义(P>0.05);治疗后,达标组杓型血压占比明显高于治疗前及未达标组,差异具有统计学意义(P<0.05);治疗后,两组的BaPWV、LVMI、尿微量白蛋白均改善,且达标组优于未达标组,差异具有统计学意义(P<0.05)。达标组靶器官损伤改善率高于未达标组,差异具有统计学意义(P<0.05)。结论经过1年的降压治疗后,高血压患者的血压变异性、血压昼夜节律以及靶器官损伤可被改善,早期降压,早期获益。     

艾灸治疗原发性高血压病的探讨

目的:探讨艾灸治疗原发性高血压病的效果。方法:将衡阳市某社区160例原发性高血压病患者随机分为试验组和对照组各80例。对照组患者仅接受原有降压药治疗;试验组患者在接受原有降压药治疗的同时进行1个月的艾灸治疗。比较两组患者的血压情况。结果:试验组艾灸治疗1个月后收缩压和舒张压明显低于对照组,差异有统计学意义(P<0.05)。结论:艾灸可有效治疗原发性高血压病。     

A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT)

As men age, the incidence of both benign prostatic hyperplasia (BPH) and hypertension increases. Concomitant occurrence of these conditions also increases with age, and the 2 are frequently encountered together in primary care practice. In addition, many patients with hypertension require >1 antihypertensive agent to adequately control blood pressure. In a multicenter, community-based, 8-week, uncontrolled, open-label study, we evaluated doxazosin, a selective alpha1-adrenergic-receptor antagonist, in 491 patients with concomitant symptomatic BPH (American Urological Association [AUA] symptom score > or =12) and hypertension, some previously untreated and some with inadequately controlled hypertension (systolic blood pressure 120-179 mm Hg or diastolic blood pressure [DBP] 80-109 mm Hg) despite taking 1 or 2 antihypertensive agents. Patients were allocated to 1 of 4 groups at baseline according to their diastolic blood pressure (control was considered DBP <90 mm Hg) and whether they had received antihypertensive medication before the study. Thus the 4 groups were treated/well-controlled, treated/poorly controlled, untreated/hypertensive, and untreated/normotensive. In all patient groups, doxazosin therapy significantly improved AUA total symptom and bothersomeness scores and BPH-specific indices of health status and interference with activities (P<0.001). Significant improvements in BPH symptoms were observed with doxazosin, regardless of whether initial symptoms were moderate or severe (P<0.001). Clinically important blood pressure lowering occurred only in the patient groups in which blood pressure had been elevated at baseline. Patients whose blood pressure was poorly controlled at baseline, either without or with treatment (predominantly with angiotensin-converting enzyme inhibitors or calcium channel blockers), achieved adequate blood pressure control (reduction to <140/90 mm Hg) with the addition of doxazosin. Similar improvements in blood pressure and BPH symptoms were seen in both older (> or =65 years) and younger (45 to 64 years) patients, and doxazosin was well tolerated by both groups. The most frequent treatment-related adverse event was dizziness (13.0% of patients); however, patients classified the dizziness as mild in approximately 75% of reports, and severe dizziness was reported by only 2 patients (0.4%). Doxazosin is an effective antihypertensive agent when used in combination with agents from other antihypertensive classes in patients with poorly controlled hypertension and BPH, and is also successful as monotherapy for controlling both BPH and hypertension in patients with mild to moderate hypertension.     

耳穴埋豆结合五行音乐疗法对四肢闭合性骨折患者疼痛的临床研究

目的 探讨耳穴埋豆结合五行音乐疗法在缓解或减轻四肢闭合性骨折患者疼痛的应用方法及效果。方法 将2018年4月至2018年12月入住上海市中西医结合医院骨伤科的59名四肢闭合性骨折患者为研究对象,按照住院时间先后,将患者分成对照组（27名）和观察组（32名）,对照组使用常规治疗护理及耳穴埋豆,观察组在对照组基础上结合五行音乐疗法,评价比较干预前后疼痛数字评价量表（NRS）、焦虑自评量表 ( SAS) 的评分变化。结果 干预前,两组患者的NRS、SAS评分无显著性差异（均P＞0.05）;干预后5、10天,观察组的NRS、SAS评分均低于对照组,有显著性差异（均 P＜0.01）。结论 耳穴埋豆结合五行音乐疗法能减轻四肢闭合性骨折患者疼痛症状。     

观察阻塞性睡眠呼吸暂停低通气综合征伴高血压患者生命质量及临床治疗效果

目的:观察阻塞性睡眠呼吸暂停低通气综合征(Obstructive Sleep Apnea Hypopnea Syndrome,OSAHS)伴高血压患者生命质量及临床治疗效果.方法:选取2017年6月至2020年6月盐城市大丰区第三人民医院收治的高血压伴阻塞性睡眠呼吸暂停低通气综合征患者60例作为研究对象,按照随机数字表...     

Compliance with antihypertensive therapy after renal artery stenting

Hypertension is an important clinical endpoint after renal artery revascularization for renal artery stenosis (RAS). Medication compliance is a critical determinant of blood pressure control. Although factors influencing compliance are known in essential hypertension, they have not been evaluated in studies investigating renal artery revascularization. The aim of this study was to assess the determinants of compliance to antihypertensive therapy in patients with RAS following renal artery stent placement (RASP). A cross-sectional study evaluating blood pressure, antihypertensive medications, quality of life, compliance, and determinants of compliance to antihypertensive therapy was undertaken in 112 patients undergoing RASP. Additionally, cardiovascular risk factors, antihypertensive medications, and cardiovascular history were reported. Self-reported compliance was 79% +/- 24% (scale of 0% [none] to 100% [complete] compliance) in patients after RASP. Determinants of compliance by multivariate analysis included physical symptoms, which correlated negatively to compliance and included loss of appetite (r2 = 0.26, P < 0.0001), dizziness (r2 = 0.06, P < 0.01), and cough (r2 = 0.03, P < 0.05). Systolic blood pressure correlated positively with compliance (r2 = 0.03, P < 0.05). The number or class of antihypertensive medications did not influence compliance. Patients' physical symptoms and level of systolic blood pressure, rather than the number or class of medications, influence compliance in patients with continued hypertension after RASP. Attention to physical symptoms may help to improve blood pressure control in this population.     

隔姜灸联合耳穴埋针治疗气滞血瘀型暴聋患者的临床疗效观察

目的 观察隔姜灸联合穴位埋针治疗气滞血瘀型暴聋的临床疗效.方法 以2018年1月至2019年12月收治于上海市宝山区中西医结合医院耳鼻喉咽科病房的气滞血瘀型暴聋患者为研究对象.将其随机分为观察组(n=40)和对照组(n=40).对照组接受常规治疗护理,观察组在此基础上增加穴位隔姜灸及埋针干预,干预10 d后,比较两组患者的听力恢复情况、伴发症发生情况及睡眠质量改善情况.结果 干预后,两组患者的听力阈值均有所减低,且观察组患者听力阈值降低程度优于对照组(P<0.001).观察组30例失眠患者的睡眠质量改善率为87％,优于对照组26例失眠患者的54％(P=0.007).治疗后,两组患者的耳鸣、耳闷、眩晕等伴发症均较之前有所改善,且观察组改善程度优于对照组(P<0.05).结论 隔姜灸联合穴位埋针的中医护理技术有助于提高气滞血瘀型暴聋患者的听力,有利于改善耳聋、耳鸣、眩晕等伴发症状及患者睡眠质量,对促进患者疾病康复、缩短住院时间有积极作用.     

耳穴压豆联合五音疗法干预慢性心力衰竭患者睡眠的临床疗效

目的:研究慢性心力衰竭(C H F)患者经耳穴压豆联合五音疗法干预后对患者睡眠质量的影响.方法:选取2018年1月至2021年10月扬州市中医院心血管内科收治的C H F失眠患者纳入62例,根据不同治疗方案分为观察组和对照组,每组各31例;其中对照组行常规治疗,观察组于对照组治疗基础上行五音疗法联合耳穴压豆进行临床治疗...